Key Record Dates
ClinicalTrials.gov Identifier: | NCT01526928 |
---|---|
Brief Title: | Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients |
First Submitted : | January 31, 2012 |
First Submitted that Met QC Criteria : | February 2, 2012 |
First Posted : | February 6, 2012 (Estimate) |
Results First Submitted : | June 11, 2019 |
Results First Submitted that Met QC Criteria : | December 17, 2019 |
Results First Posted : | January 6, 2020 |
Last Update Submitted that Met QC Criteria : | July 26, 2020 |
Last Update Posted : | August 4, 2020 |